As vaccine panel prepares hepatitis B review, CDC and industry experts are excluded
CDC experts and manufacturers haven't been consulted for an ACIP review of hepatitis B vaccine, raising concerns over any change in the vaccine schedule.
STAT+: ACA tax credits cool, while BIOSECURE heats up
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.
STAT+: After Elsa, FDA rolls out ‘agentic AI’ for staff
In this edition of STAT's Health Tech newsletter: FDA rolls out agentic AI for staff, and news about a radiology acquisition, chatbots.
STAT+: Top drug regulator Richard Pazdur set to leave the FDA
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, raising concerns about agency turnover.
STAT+: A drug that was ‘engineered with AI’ enters Phase 3 testing
And more biotech news, brought to you by The Readout newsletter
STAT+: Pharmalittle: We’re reading about hospitals suing to halt a 340B pilot, hepatitis B vaccine studies, and more
The American Hospital Association and several hospital systems are suing the Trump Administration over an upcoming 340B pilot program
Days before ACIP meeting, committee chair gets a new job at HHS
And other health news from the Morning Rounds newsletter
Expert review finds delaying the hepatitis B vaccine birth dose would increase chronic infections in kids
Delaying the timing of vaccinating infants against hepatitis B — which ACIP could vote on later this week — would likely lead to more chronic infections in kids.
STAT+: CDC staff with disabilities feel stranded as HHS implements new policy
CDC is asking employees seeking telework as a reasonable accommodation to return to the office until their requests can be processed under a new HHS policy.
STAT+: Marion Nestle still believes that ‘calories count’
Nutrition expert Marion Nestle's latest book is a call to action for Americans to advocate for a better food system.